[Impacto]

Cause you don't want it ;)

[waterchaser]

Why? There’s nothing here but some severely disappointed pumpers.

[Impacto]

Adding !!!!!

[Impacto]

Yep. People are so stupid not to buy now imo!

[skyhawk66]

CANB up from .01 to a high of .17 in less then 2 months. Loading Again at these oversold levels is a No Brainer.
Next Record Breaking Quarter is about to be released $$$$

[Impacto]

So? Don't buy it then. I am buying a lot. Way cheap now!

[MBEANS]

Stock sucks. Down from 16 less than 3 weeks ago despite the patent news.

[Impacto]

Why not ?

[MBEANS]

Why

[Impacto]

Adding !!!!!

[Premium Stocks]

5 x regular volume today

[Premium Stocks]

Anyone heard of RED ROCK ?

[Premium Stocks]

RED ROCK SELLING , I heard 1 billion shares

[waterchaser]

I think I can guess which scammer brought you to CANB.

Under the new IHUB rules, you are welcome to identify the perp.

[MBEANS]

what a piece of shit this stock is. Should know by now that all stocks referred to me by >>>>??? will lose me a ton of money. Shame on me for believing the "promised land" is around the corner.

[skyhawk66]

Over 12% gain today lady. And on strong volume, was that you buying CANB again?

[waterchaser]

I forget which scam pumpers brought me to CANB…
but I think it was scammers Sleek and his assistants Sky and Badguy.

My memory isn’t great, but if you research the CANB MJ scam…
And research Sleek, Sky and Badguy, you will see who the perps were/are.

There needs to be an investigation.

The CANB evidence of a scam pump on this IHUB Board is clear and undeniable.

[skyhawk66]

Lol, no worries BG, those 2 Ladies are the joke of the OTC, lol.
CANB massive Loading by Investors since last month, down on low volume is expected.
CANB Long Term 2024…And Beyond:)

[badguy3101]

CANB NASDAQ
Just put those 2 clowns on ignore. Best thing I ever did!



The Badguy

[waterchaser]

Almost 12% drop today. I wonder what-the-pump spin will be to distort reality this time.

Wait for it… it will come soon enough.

[skyhawk66]

First it was heavy selling, then it was heavier then normal, next it’s normal selling? What price range are you looking to buy more at this time around Miss wet chaser? Your are definitely an OTC Lover, keep it up, lol!

[waterchaser]

Swing and a miss there Scammer.
Monday (two days ago) CANB closed down 11% on heavier than normal volume.

[skyhawk66]

Lol, Another Desperate misleading attempt by our OTC loving community paid Basher Miss wetchaser, sorry low volume day yesterday and today so far.
CANB, .01’s to a high of .17 in a month and a half. And more to come as Another Record Quarter Approaches $$$
Heard your loading as well on any dips, you are a tricky snake, lol.

[waterchaser]

Heavy selling today on the fluff news.
Some things never change on the scam OTC.
Pump it, then dump it… collateral damage nubies be damned.
Who cares if they are duped by the likes of sky and sleek.

[waterchaser]

I aim to please.

Sooo glad you Follow CANB 24/7

[skyhawk66]

Here is where you Always miss out on Gains….Again. CANB was at .01 last month and half and reached a high of .17 last week.
Miss. You will never learn, Sooo glad you Follow CANB 24/7, must be painful, LOL :)

[waterchaser]

CANB lost 11% on “excellent news” today?
Welcome to the scam OTC.
Dump into fluff news… S.O.P.

[waterchaser]

OTC pump garbage.

[Premium Stocks]

$750,000,000 by 2034 capitulation on the patents they now own

[Premium Stocks]

You didn’t see the huge press release ??

[skyhawk66]

Miss, your hatred for OTC stocks will continue to make you loose out on massive profits, so sad :(
Great dedication on follow daily though, LOL!

[waterchaser]

Sounds like stinky pinky bullshit to me.

[skyhawk66]

CANB-Good News Release today,,no wonder strong Accumulation has been going on for almost 2 months at these discounted Prices. Next up, Another Record Breaking Quarter.

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
The Patents Term – Presumed Valid By Law – Extends to 2035
HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation (OTCQB: CANB) (“Can B”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products, is pleased to announce that it has secured ownership and control of two cannabis patents that were valued at $122 million, applying a 90% discount and assuming a revenue stream through August 2034, and further based on only CBD claims and only in the U.S. It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.
The two composition and use patents covering cannabis extracts and methods of preparing the same were acquired through Can B’s 67% owned subsidiary, Nascent Pharma, LLC, and are: (1) US 9,730,911 B2 (granted August 15, 2017) and (2) US 10,555,928 B2 (granted February 11, 2020). These patents were previously awarded to United Cannabis Corporation and recently assigned to Can B by a court procedure.
The patents were valued at $122 million in December 2020 by an independent third-party valuation team, which used a 90% discount rate due to the emerging nature of the industry. The valuation of the patents included only CBD claims and only in the U.S. Since the date of the valuation, the patents have become effective in Canada, Australia, New Zealand, Israel, and Brazil and have received additional divisional patents in the U.S. The priority date for the patents stems back to October 2013 and have pending status in the European Union, India, China, Eurasia, South Korea, Mexico, Japan, and Colombia.
Of significance, the patents survived an earlier invalidity challenge in Federal Court. The defendants claim that the patent formulation was a naturally occurring substance (which is not patentable). The court ruled that it was not, thereby denying the objection.
The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis.
The patents include both a composition of matter patent and a method of use patent. The composition of matter patent covers liquid formulations of cannabis where the present cannabinoids are more than 95% CBD, THC, CBN, CBDa, THCa, or several combinations thereof. This patent covers beverages, tinctures, vape pen liquids and liquid filled capsules. This constitutes a considerable portion of the hemp and cannabis industry, potentially up to 50%.
The method of use patent uses some of the composition of matter combinations to potentially manage many debilitating conditions. These include cancer, IBS, chronic pain, PTSD, anxiety, sleep disorders and opioid dependencies.
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are thrilled to be the proud new owners of these extremely important and potentially very valuable cannabis patents. While cannabis stocks have been in a bear market for the past few years, there is no doubt that the industry has witnessed robust growth and has become more and more acceptable, legal and mainstream, despite still being considered a Schedule I drug under the Controlled Substances Act. We believe there is a strong opportunity to monetize these patents as they represent important innovations in this industry. We look forward to updating shareholders and the public with our plans going forward.”
About Can B Corp.
Can B is a health & wellness company providing quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B’s Duramed medical device division operates out of its New York office provides durable medical devices in the “No-Fault” insurance space. Can B operates its hemp operating division in its Colorado facilities. Nascent Pharma is Can B’s newest operation in the patent and intellectual property arena. To learn more about Can B and our comprehensive line of high quality products, please visit: Canbiola.com and www.CanBCorp.com; follow Can B on Instagram @canbcorp and Facebook @ Can B Corp, Twitter @CanBCorp, YouTube @canbiola9412, or visit one of the retail outlets that carry Can B products.

[Haymaker1]

I see the 8K news came out today, What they blatantly failed to mention was the 50% as shown below..only in Pinky land,

The Company has entered into a consulting agreement with the inventor who assigned the patents to Nascent which provides that the consultant will be entitled to fifty percent (50%) of distributions received by Company from Nascent.

[skyhawk66]

No wonder Accumulation Continues at these Oversold Levels.
CANB, next test 6Month High :)

[skyhawk66]

CANB Continues to Impress in its Continued 2nd month rally. Next stop 6 month High as Accumulation Continues before it’s Next Record Quarter is released.
Miss, take your OTC blindfold off and make up for your past losses ;)

[waterchaser]

Lololol! A stinky pinky acquires assets worth $122,000,000!
Welcome to the fantasy world of the scam OTC.

An independent valuation firm valued the patents at $122,000,000 in 2020

[Haymaker1]

ITEM 8.01. OTHER EVENTS.



Can B Corp. (the “Company”) announced today that through its 67% owned subsidiary, Nascent Pharma, LLC (“Nascent”), it has acquired composition of matter and use patents (US 9,730,911 B2 granted August 15, 2017 and US 10,555,928 B2 granted February 11, 2020) covering liquid formulations of cannabis, including, among other things, beverages, tinctures, vape pen liquids and liquid filled capsules. Patented uses include using the liquid formulations to manage numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post traumatic stress disorder, anxiety, sleep disorders and opioid dependencies. Through Nascent, the Company plans to pursue opportunities to license and develop uses for the patents.



An independent valuation firm valued the patents at $122,000,000 in 2020, after taking into account the present value of projected income streams, applying a 90% discount and assuming a revenue stream through August 2034. No assurance can be given that the patents will ultimately provide a revenue stream to the Company or that value of the patents will equal the value determined by the independent valuation firm.



In connection with the assignment of the patents to Nascent, Nascent has agreed to distribute to creditors of a prior owner of the patents five percent (5%) of the Company’s share of Nascent’s revenues, less a reserve for Nascent’s operating expenses and amounts repaid to Nascent investors, until the creditors have received aggregate payments of $10,000,000.



The Company has entered into a consulting agreement with the inventor who assigned the patents to Nascent which provides that the consultant will be entitled to fifty percent (50%) of distributions received by Company from Nascent.

[skyhawk66]

CANB Accumulation on high Volume continues before Another Record Quarterly Earnings Report is released.
Basher, Take your OTC blinders off and make some money Miss.

[waterchaser]

I have a pretty good record of identifying IHUB scammers and calling them out for what they are.

If just one possible CANB investor heads my warnings about you and sleek and your nefarious ways, I'm a happy man.

[skyhawk66]

More like Great job bashing for cash, I know your children are definitely not proud of you Miss, so Sad :(

[waterchaser]

Great job of scamming the less informed!
Your children must be so proud of you.
Pump CANB heavily, then dump on those that don't know the IHUB scammer's game.
Brilliant!

[skyhawk66]

Typical, you missed the run Again so Bash it, LOL. Lady when will you learn :(